← Evidence map

ArticleBiomedical reports2018

CYP2D63 (A2549del), 4 (G1846A), 10 (C100T) and 17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen.

Fatemeh Saghafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2018

2019

2020

2021

2022

2023

2024

this papercites it

CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen. | OpenQuestion